Motoi, S.; Uesugi, M.; Obara, T.; Moriya, K.; Arita, Y.; Ogasawara, H.; Soejima, M.; Imai, T.; Kawano, T.
Serum APOA4 Pharmacodynamically Represents Administered Recombinant Human Hepatocyte Growth Factor (E3112). Int. J. Mol. Sci. 2021, 22, 4578.
https://doi.org/10.3390/ijms22094578
AMA Style
Motoi S, Uesugi M, Obara T, Moriya K, Arita Y, Ogasawara H, Soejima M, Imai T, Kawano T.
Serum APOA4 Pharmacodynamically Represents Administered Recombinant Human Hepatocyte Growth Factor (E3112). International Journal of Molecular Sciences. 2021; 22(9):4578.
https://doi.org/10.3390/ijms22094578
Chicago/Turabian Style
Motoi, Sotaro, Mai Uesugi, Takashi Obara, Katsuhiro Moriya, Yoshihisa Arita, Hideaki Ogasawara, Motohiro Soejima, Toshio Imai, and Tetsu Kawano.
2021. "Serum APOA4 Pharmacodynamically Represents Administered Recombinant Human Hepatocyte Growth Factor (E3112)" International Journal of Molecular Sciences 22, no. 9: 4578.
https://doi.org/10.3390/ijms22094578
APA Style
Motoi, S., Uesugi, M., Obara, T., Moriya, K., Arita, Y., Ogasawara, H., Soejima, M., Imai, T., & Kawano, T.
(2021). Serum APOA4 Pharmacodynamically Represents Administered Recombinant Human Hepatocyte Growth Factor (E3112). International Journal of Molecular Sciences, 22(9), 4578.
https://doi.org/10.3390/ijms22094578
